Gencor Releases Third Quarter Fiscal 2017 Results
Aug 03, 2017 12:35 pm UTC| Business
ORLANDO, Fla., Aug. 03, 2017 -- Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenue for the quarter ended June 30, 2017 increased 19.5% to $23.7 million from $19.9 million for the quarter ended June 30,...
Aug 03, 2017 12:35 pm UTC| Business
Hollywood, FL, Aug. 03, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid, nutraceutical, pharmaceutical, and...
Numerex Corp. Announces Plan to Merge with Sierra Wireless
Aug 03, 2017 12:30 pm UTC| Business
ATLANTA, Aug. 03, 2017 -- Numerex Corp. (“Numerex” or the “Company”) (NASDAQ:NMRX), a leading provider of enterprise solutions enabling the Internet of Things, (IoT), and Sierra Wireless, Inc. (“Sierra Wireless”)...
Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference
Aug 03, 2017 12:30 pm UTC| Business
SAN DIEGO and TORONTO, Aug. 03, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today...
Aug 03, 2017 12:30 pm UTC| Business
WARREN, N.J., Aug. 03, 2017 -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration (FDA) on the Phase 2 study...
Ubiquiti Networks Reports Preliminary Fourth Quarter Fiscal 2017 Financial Results
Aug 03, 2017 12:30 pm UTC| Business
~ Achieves Record Revenue and Eighth Consecutive Quarter of Revenue Growth ~ ~Provides Revenue Outlook for Fiscal 2018 of $1.0 billion - $1.15 billion~ ~The Company to Host Investor Update Meeting on September 26,...
Aug 03, 2017 12:30 pm UTC| Business
MADISON, Wis., Aug. 03, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today announces that management will host a teleconference and live...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight